Amylyx Pharmaceuticals, Inc. AMLX Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Amylyx Pharmaceuticals, Inc.’s reported figures.
The official record: Amylyx Pharmaceuticals, Inc.’s 10-K, filed March 3, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amylyx Pharmaceuticals, Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amylyx Pharmaceuticals, Inc.'s free cash flow?
- Amylyx Pharmaceuticals, Inc. (AMLX) reported free cash flow of -$27.99M in Q4 2025.
- How has Amylyx Pharmaceuticals, Inc.'s free cash flow changed year-over-year?
- Amylyx Pharmaceuticals, Inc.'s free cash flow increased by 52.6% year-over-year, from -$59.03M to -$27.99M.
- What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s free cash flow?
- Over 4 years (2021 to 2025), Amylyx Pharmaceuticals, Inc.'s free cash flow has grown at a 13.2% compound annual growth rate (CAGR), from -$75.15M to -$123.48M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.